.The new coronary pneumonia (COVID-19) vaccine developed by the Chinese company Cansino Biosciences has launched a phase III clinical trial in Russia. Russian biopharmaceutical company Petrovax said on January 14 that the trial showed that as many as 92.5% of participants had a large number of antibodies.
The company also stated that the trial had no adverse side effects.
Ad5-nCoV vaccine adopts adenovirus vector platform technology. Since September 2020, Phase III clinical trials have been launched in Russia. After this vaccine, Phase III trials have been launched in Mexico and Pakistan
quite difficult as glove hardly can have show. look at big 4 kena throw like nobody. Majority investor earned and run. Nowadays talking about glove counter like see ghost.
Basically all these news is not so important as the owner is not a decent man. TCH is a famous goreng kaki in share market. just follow the wave the buy at low then pull out at right time.
I already told you guys that it is inaccurate news that Inix submitted the application to NPRA but you guys don't believe me. Inix just wants to goreng up the share price thats all.
In light of the seriousness of the implications arising out of the Article entitled “INIX Technologies’ application to supply Covid-19 vaccines yet to be received by NPRA” (“the misleading and damaging statement”) published by The Edge Markets on its online portal at 9:00 am on Wednesday (January 20, 2021), INIX Technologies Holdings Berhad (“the Company”) has instructed its lawyer to seek appropriate legal recourse which shall include a demand from the author and the publisher of the article to retract the misleading and damaging statement and to publish an appropriate apology and clarification. The Company will also seek an undertaking that the author and publisher of the article shall not repeat the statements in any form. In the meantime, the Company shall reserve all the rights whatsoever.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Valueinvestor
2,121 posts
Posted by Valueinvestor > 2021-01-17 16:44 | Report Abuse
Solution and bintai will benefited 1st.